Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cleveland Biolabs Inc (NASDAQ:CBLI)

3.12
Delayed Data
As of Jul 01
 +0.14 / +4.70%
Today’s Change
1.92
Today|||52-Week Range
5.29
-10.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues3.6M8.5M3.7M2.7M
 
 
 
 
 
Depreciation And Amortization479.6K471.2K841.0K140.1K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses33.1M30.6M17.2M13.4M
 
 
 
 
 
Other Operating Expenses0.000.000.001.1M
 
 
Research And Development22.5M19.0M9.6M7.1M
 
 
 
 
 
Total Operating Expenses33.6M31.1M18.1M14.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-30.0M-22.6M-14.4M-11.9M
 
 
 
 
 
Extraordinary Credit7.7M2.9M2.7M0.00
 
 
 
 
Extraordinary Charge0.00-506.2K-33.1K0.00
 
 
 
Pre-Tax Equity Earnings407.4K217.3K-285.5K-362.1K
 
 
 
 
 
Interest Expense On Debt477.4K134.2K1.1M99.5K
 
 
 
 
 
Other Expenses0.000.0013.2M-731.4K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.4M-20.1M35.4K-13.0M
 
 
 
 
 
Minority Interest-4.2M-2.9M-1.6M-407.3K
 
 
 
 
 
Net Income-18.2M-17.3M1.6M-12.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.9M2.3M2.7M7.1M
 
 
 
 
 
Shares To Calculate EPS Diluted1.9M2.3M2.7M7.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$9.80-$7.60$12.00-$1.79
 
 
 
 
 
EPS Diluted-$9.80-$7.60$0.60-$1.79